What compliance and billing challenges can arise when multiple hospital departments perform laboratory testing, particularly with point-of-care testing (POCT)? In this regard, do you have any insight into billing modifier 91?
Can you provide any insight or coding tips for codes 76014 and 76015? Specifically, can we charge 76014 for every patient with an implanted device if we must review prior documentation to determine whether the device is MRI-compatible?
When is modifier 91 applicable for testing?
What are the new category III codes effective as of 2026?
If a patient is scheduled for a CT with and without contrast, but the patient refuses the contrast, should we bill the code for the CT without contrast, or should we bill for the exam with/without a modifier? What modifier would be appropriate to use in this scenario?
Is code 86985 billable with P9011?
What are the new category III codes effective as of 2026?
What APC is code 94200 assigned to?
When is a one-time HCV screening test covered for adults who do not meet the high risk definition?
Can you tell us how many times the new 2026 add-on codes for lithotripsy can be reported per iliac territory and femoral/popliteal territory?
To whom is code 88291 billable when reporting cytogenetics and molecular cytogenetics interpretation and report?
How do you bill for a split-night sleep study?
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24Â
